Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflabloc Cap (DHEA) in Moderately Active Crohn's Disease
NCT00106314Phase 2Completed
- Sponsor
- Inflabloc Pharmaceuticals
- Start
- Jan 2005
- Modality
- Allosteric Modulators
- Countries
- 2
01
Overview
A Phase 2 trial of dehydroepiandrosterone in Crohn's disease, sponsored by Inflabloc Pharmaceuticals. Started Jan 2005; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00106314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106314.